Emergence Capital

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026

Emergence Capital backs early-stage B2B software companies, with a focus on technologies that change how businesses and their employees work.

Its company-building experience includes developing enterprise sales alongside product-led growth, recruiting leadership and introducing early customers. The firm’s work with Zoom included building an enterprise sales motion; Together AI credits Emergence with an introduction that led to its first enterprise customer.

Emergence publishes operating playbooks and research on AI-native services and software-company benchmarks. These resources address the commercial and organisational decisions founders face when taking a new product into business workflows.

Sources
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$80M
2 disclosed · full round size, not this investor’s share

By stage

Seed1
Series A1

By primary sector

Biotech1
Healthtech1

By country

United States2

Rounds

2 in this selection
Prosper AI

Automates the patient journey from scheduling and insurance to billing and collections

$30MSeries A
Role not disclosed
Radical Numerics

Builds multimodal AI models that read, write, and design across DNA, RNA, and proteins

$50MSeed
Role not disclosed